Toward a neuroimaging treatment selection biomarker for major depressive disorder.
about
On the Origin of InteroceptionRole of Hybrid Brain Imaging in Neuropsychiatric DisordersStudying depression using imaging and machine learning methodsComparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysisBrain Functional Effects of Psychopharmacological Treatment in Major Depression: a Focus on Neural Circuitry of Affective ProcessingInteroceptive predictions in the brainTreatment decisions based on scalar and functional baseline covariates.The neuroscience of depression: implications for assessment and intervention.Rightward dominance in temporal high-frequency electrical asymmetry corresponds to higher resting heart rate and lower baroreflex sensitivity in a heterogeneous population.A bihemispheric autonomic model for traumatic stress effects on health and behavior.Insula and striatum activity in effort-related monetary reward processing in gambling disorder: the role of depressive symptomatologyMagnetic resonance imaging predictors of treatment response in late-life depression.Neuroimaging for psychotherapy research: current trendsPrediction as a humanitarian and pragmatic contribution from human cognitive neuroscienceNeuroimaging-based biomarkers for treatment selection in major depressive disorder.In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.How to Perform and Interpret Functional Magnetic Resonance Imaging Studies in Functional Gastrointestinal DisordersMajor depressive disorder is associated with abnormal interoceptive activity and functional connectivity in the insulaComputational psychiatry as a bridge from neuroscience to clinical applications.Pretreatment brain states identify likely nonresponse to standard treatments for depression.Biomarker Development for Brain-Based Disorders: Recent Progress in PsychiatryPredicting clinical outcome using brain activation associated with set-shifting and central coherence skills in Anorexia Nervosa.Model specification and the reliability of fMRI results: implications for longitudinal neuroimaging studies in psychiatry.Diagnostic and therapeutic utility of neuroimaging in depression: an overviewTest-retest reliability of pain-related brain activity in healthy controls undergoing experimental thermal painDeep brain stimulation (DBS) at the interface of neurology and psychiatryResting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases.Psychotherapy and NeuroimagingThe promise of cognitive behavior therapy for treatment of severe mental disorders: a review of recent developments.Interventional psychiatry: why now?Functional and structural alterations in the cingulate motor area relate to decreased fronto-striatal coupling in major depressive disorder with psychomotor disturbances.Telephone and in-person cognitive behavioral therapy for major depression after traumatic brain injury: a randomized controlled trialUsing biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies.Role of functional imaging in the development and refinement of invasive neuromodulation for psychiatric disorders.Clinical, cognitive, and functional connectivity correlations of resting-state intrinsic brain activity alterations in unmedicated depressionAltering the Cognitive-Affective Dysfunctions of Psychopathic and Externalizing Offender Subtypes with Cognitive Remediation.Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive DisorderComputational meta-analysis of statistical parametric maps in major depression.Lateralization for speech predicts therapeutic response to cognitive behavioral therapy for depression
P2860
Q26744707-387D68B6-4668-4FA7-8507-41D0D68FD3FDQ26768454-08B3F54C-A5FC-466D-8761-5BECD16CB626Q26772163-66479F17-8DAC-4D1E-B806-52EFE05FBC00Q26773538-06A24BF4-FB19-4516-8C3D-1CA993DB89E9Q26786234-AE599196-8BFE-49D6-85EF-113E8DEAB7AAQ26999472-7C93FD45-3564-40AE-940C-EEDDF732914FQ27314834-AC310C76-C71F-43CB-832C-60D07C2508FAQ30399725-26D90EB1-D488-4BF9-957A-D0B80BD440E3Q30409091-F3E3E64D-D884-41B7-A61A-B6553ACDCDCFQ30432864-2BA42339-17DB-4138-B687-FAC35C39EBCAQ30596662-A45F3FDE-8E83-42CB-91D3-ED813F2AA362Q30724972-154B632A-5F29-4919-8826-D03581A46A4AQ30757175-870DFBE0-931F-4C0F-A00C-13927ACB9918Q30883311-1685A025-AD45-43C7-A2D1-540F4B401A10Q30903129-2F04C0B0-D081-4824-98ED-BA8C65B89496Q30927398-DA36F189-8E27-4EBC-B7F5-60C056EB031BQ31170243-8F1F9B99-BA2E-427D-96AD-E34136957FDDQ33723825-A73946EC-3A1C-4C0B-960E-ADF89BB5B4CCQ33724477-5E3BE394-60E8-447C-8E7E-E33C65CC2B56Q33779403-4500CC75-75C7-4BDD-B913-6C9D8D4DFDEFQ34010400-B53B68B6-E1DF-4862-8A9D-77DC558DFD87Q34022807-001E15C2-8286-456A-947C-61C82ED2DBCDQ34104926-6E644FD0-627C-4455-838C-0E01023F298FQ34109804-9316F484-2ED4-4E00-A77F-DC26E58994E8Q34276061-63E12F8F-F63E-40B8-888D-AD703B23D9CAQ34381701-CE091D38-BE7C-44F9-9DD1-2323CD2CAB9BQ34384076-20D87ADB-D42D-4F11-93AB-78067B04B85BQ34393191-037B17A9-FF1E-4FBF-82A0-ECC8471A38DAQ34447066-F3D939F8-7CE4-42F6-A46A-6DDAFC46E5DCQ34457388-88619231-EC65-4815-A34A-1F7B6AD07BEFQ34630380-0F477809-8D11-4560-808D-F772F3EE77B8Q34751423-ABA1924F-F5CC-4330-8439-27C9D65853B0Q35109175-300E9CA0-240E-41D4-90D2-1F7ACB31D0A6Q35370603-AF302933-68BC-44E0-B5D8-7E1ECC15E4FBQ35471915-ADC22294-CAF0-4C25-9691-122F2C5B06ACQ35589886-F84936AB-2648-4A13-A204-80BCA78645F8Q35731471-4652B6EF-7922-446B-AD2F-54DD3C542B8CQ35795101-9E1D3301-2431-497E-B209-5AB165348221Q35917018-E68B2427-AD1E-4F9F-B217-E75F1405628FQ35940582-A2FB6D9D-F8A4-4538-A6C7-6D0EA08FE360
P2860
Toward a neuroimaging treatment selection biomarker for major depressive disorder.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Toward a neuroimaging treatment selection biomarker for major depressive disorder.
@ast
Toward a neuroimaging treatment selection biomarker for major depressive disorder.
@en
type
label
Toward a neuroimaging treatment selection biomarker for major depressive disorder.
@ast
Toward a neuroimaging treatment selection biomarker for major depressive disorder.
@en
prefLabel
Toward a neuroimaging treatment selection biomarker for major depressive disorder.
@ast
Toward a neuroimaging treatment selection biomarker for major depressive disorder.
@en
P2093
P2860
P1433
P1476
Toward a neuroimaging treatment selection biomarker for major depressive disorder.
@en
P2093
Callie L McGrath
Helen S Mayberg
Mary E Kelley
Paul E Holtzheimer
R Cameron Craddock
W Edward Craighead
P2860
P304
P356
10.1001/JAMAPSYCHIATRY.2013.143
P407
P577
2013-08-01T00:00:00Z